Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses

Immunity

Volumn 44, Issue 6, 2016, Pages 1379-1391

  Zhao, Jincun ^a,b   Zhao, Jingxian ^b   Mangalam, Ashutosh K ^c   Channappanavar, Rudragouda ^b   Fett, Craig ^b   Meyerholz, David K ^c   Agnihothram, Sudhakar ^d,f   Baric, Ralph S ^d   David, Chella S ^e   Perlman, Stanley ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d IL   (United States)

^e MAYO GRADUATE SCHOOL   (United States)

^f CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; VIRUS ANTIGEN; VIRUS VACCINE;

ANIMAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CORONAVIRUS INFECTION; CROSS REACTION; HUMAN; IMMUNITY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INBRED MOUSE STRAIN; METABOLISM; MOUSE; RESPIRATORY SYSTEM; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VACCINATION; VIRION; VIROLOGY;

ANIMALS; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CORONAVIRUS INFECTIONS; CROSS REACTIONS; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNITY; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; MICE; MICE, INBRED STRAINS; RESPIRATORY SYSTEM; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VACCINATION; VIRAL VACCINES; VIRION;

EID: 84973517439     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2016.05.006     Document Type: Article

References (41)

1. Agnihothram S., Gopal R., Yount B.L., Donaldson E.F., Menachery V.D., Graham R.L., Scobey T.D., Gralinski L.E., Denison M.R., Zambon M., Baric R.S. Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses. J. Infect. Dis. 2014, 209:995-1006.
2. Anderson K.G., Sung H., Skon C.N., Lefrancois L., Deisinger A., Vezys V., Masopust D. Cutting edge: intravascular staining redefines lung CD8 T cell responses. J. Immunol. 2012, 189:2702-2706.
3. Bolles M., Deming D., Long K., Agnihothram S., Whitmore A., Ferris M., Funkhouser W., Gralinski L., Totura A., Heise M., Baric R.S. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge. J. Virol. 2011, 85:12201-12215.
4. Channappanavar R., Zhao J., Perlman S. T cell-mediated immune response to respiratory coronaviruses. Immunol. Res. 2014, 59:118-128.
5. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 2004, 303:1666-1669. Chinese SARS Molecular Epidemiology Consortium.
6. Frieman M.B., Chen J., Morrison T.E., Whitmore A., Funkhouser W., Ward J.M., Lamirande E.W., Roberts A., Heise M., Subbarao K., Baric R.S. SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism. PLoS Pathog. 2010, 6:e1000849.
7. Ge X.Y., Li J.L., Yang X.L., Chmura A.A., Zhu G., Epstein J.H., Mazet J.K., Hu B., Zhang W., Peng C., et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 2013, 503:535-538.
8. Harcourt G.C., Garrard S., Davenport M.P., Edwards A., Phillips R.E. HIV-1 variation diminishes CD4 T lymphocyte recognition. J. Exp. Med. 1998, 188:1785-1793.
9. Hufford M.M., Kim T.S., Sun J., Braciale T.J. Antiviral CD8+ T cell effector activities in situ are regulated by target cell type. J. Exp. Med. 2011, 208:167-180.
10. Iwata-Yoshikawa N., Uda A., Suzuki T., Tsunetsugu-Yokota Y., Sato Y., Morikawa S., Tashiro M., Sata T., Hasegawa H., Nagata N. Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine. J. Virol. 2014, 88:8597-8614.
11. Lees J.R., Farber D.L. Generation, persistence and plasticity of CD4 T-cell memories. Immunology 2010, 130:463-470.
12. Li W., Shi Z., Yu M., Ren W., Smith C., Epstein J.H., Wang H., Crameri G., Hu Z., Zhang H., et al. Bats are natural reservoirs of SARS-like coronaviruses. Science 2005, 310:676-679.
13. Ma C., Wang L., Tao X., Zhang N., Yang Y., Tseng C.T., Li F., Zhou Y., Jiang S., Du L. Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design. Vaccine 2014, 32:6170-6176.
14. MacLeod M.K., Kappler J.W., Marrack P. Memory CD4 T cells: generation, reactivation and re-assignment. Immunology 2010, 130:10-15.
15. Masopust D., Picker L.J. Hidden memories: frontline memory T cells and early pathogen interception. J. Immunol. 2012, 188:5811-5817.
16. McKinstry K.K., Strutt T.M., Kuang Y., Brown D.M., Sell S., Dutton R.W., Swain S.L. Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms. J. Clin. Invest. 2012, 122:2847-2856.
17. Moran T.P., Collier M., McKinnon K.P., Davis N.L., Johnston R.E., Serody J.S. A novel viral system for generating antigen-specific T cells. J. Immunol. 2005, 175:3431-3438.
18. Mueller S.N., Gebhardt T., Carbone F.R., Heath W.R. Memory T cell subsets, migration patterns, and tissue residence. Annu. Rev. Immunol. 2013, 31:137-161.
19. Oh H.L., Chia A., Chang C.X., Leong H.N., Ling K.L., Grotenbreg G.M., Gehring A.J., Tan Y.J., Bertoletti A. Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope. J. Virol. 2011, 85:10464-10471.
20. Peiris J.S., Guan Y., Yuen K.Y. Severe acute respiratory syndrome. Nat. Med. 2004, 10(12, Suppl):S88-S97.
21. Peng H., Yang L.T., Wang L.Y., Li J., Huang J., Lu Z.Q., Koup R.A., Bailer R.T., Wu C.Y. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. Virology 2006, 351:466-475.
22. Purwar R., Campbell J., Murphy G., Richards W.G., Clark R.A., Kupper T.S. Resident memory T cells (T(RM)) are abundant in human lung: diversity, function, and antigen specificity. PLoS ONE 2011, 6:e16245.
23. Roberts A., Deming D., Paddock C.D., Cheng A., Yount B., Vogel L., Herman B.D., Sheahan T., Heise M., Genrich G.L., et al. A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog. 2007, 3:e5.
24. Scobey T., Yount B.L., Sims A.C., Donaldson E.F., Agnihothram S.S., Menachery V.D., Graham R.L., Swanstrom J., Bove P.F., Kim J.D., et al. Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. USA 2013, 110:16157-16162.
25. Slütter B., Pewe L.L., Kaech S.M., Harty J.T. Lung airway-surveilling CXCR3(hi) memory CD8(+) T cells are critical for protection against influenza A virus. Immunity 2013, 39:939-948.
26. Stockinger B., Bourgeois C., Kassiotis G. CD4+ memory T cells: functional differentiation and homeostasis. Immunol. Rev. 2006, 211:39-48.
27. Sui J., Deming M., Rockx B., Liddington R.C., Zhu Q.K., Baric R.S., Marasco W.A. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness. J. Virol. 2014, 88:13769-13780.
28. Sun J., Madan R., Karp C.L., Braciale T.J. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 2009, 15:277-284.
29. + T cells in immunity to viruses. Nat. Rev. Immunol. 2012, 12:136-148.
30. Tang F., Quan Y., Xin Z.T., Wrammert J., Ma M.J., Lv H., Wang T.B., Yang H., Richardus J.H., Liu W., Cao W.C. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study. J. Immunol. 2011, 186:7264-7268.
31. Teijaro J.R., Turner D., Pham Q., Wherry E.J., Lefrançois L., Farber D.L. Cutting edge: Tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J. Immunol. 2011, 187:5510-5514.
32. Tonkin D.R., Whitmore A., Johnston R.E., Barro M. Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles. Vaccine 2012, 30:4532-4542.
33. Trandem K., Zhao J., Fleming E., Perlman S. Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis. J. Immunol. 2011, 186:3642-3652.
34. Turner D.L., Farber D.L. Mucosal resident memory CD4 T cells in protection and immunopathology. Front. Immunol. 2014, 5:331.
35. Wang X., Liao Y., Yap P.L., Png K.J., Tam J.P., Liu D.X. Inhibition of protein kinase R activation and upregulation of GADD34 expression play a synergistic role in facilitating coronavirus replication by maintaining de novo protein synthesis in virus-infected cells. J. Virol. 2009, 83:12462-12472.
36. Wilkinson T.M., Li C.K., Chui C.S., Huang A.K., Perkins M., Liebner J.C., Lambkin-Williams R., Gilbert A., Oxford J., Nicholas B., et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 2012, 18:274-280.
37. Woo P.C., Lau S.K., Wong B.H., Chan K.H., Hui W.T., Kwan G.S., Peiris J.S., Couch R.B., Yuen K.Y. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide. J. Clin. Microbiol. 2004, 42:5885-5888.
38. Zhao J., Zhao J., Perlman S. T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice. J. Virol. 2010, 84:9318-9325.
39. Zhao J., Zhao J., Legge K., Perlman S. Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. J. Clin. Invest. 2011, 121:4921-4930.
40. Zhao L., Jha B.K., Wu A., Elliott R., Ziebuhr J., Gorbalenya A.E., Silverman R.H., Weiss S.R. Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host Microbe 2012, 11:607-616.
41. Zhao J., Li K., Wohlford-Lenane C., Agnihothram S.S., Fett C., Zhao J., Gale M.J., Baric R.S., Enjuanes L., Gallagher T., et al. Rapid generation of a mouse model for Middle East respiratory syndrome. Proc. Natl. Acad. Sci. USA 2014, 111:4970-4975.